Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for ...
News-Medical.Net on MSN
Novel drug combination overcomes resistance in aggressive KRAS-mutated lung cancer
A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and ...
One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs ...
Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for therapeutics. Among them, the Y220C mutation is the ninth most frequent and it ...
A mutated strain of influenza A, H3N2 subclade K, is surging worldwide, sparking concern about a severe flu season in the ...
The discovery shifts the paradigm from outsmarting cancer’s adaptations to exploiting them. By crowdsourcing resistance ...
Nirsevimab (Beyfortus), an antibody targeting respiratory syncytial virus (RSV), is indicated for newborns and infants to prevent bronchiolitis. Available since September 2023, its widespread use may ...
HIV virus is one of the most pressing health concerns facing the modern world. Since the first reported case of HIV/AIDS in 1981, over 25 million people have died. Out of the millions of people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback